Affiliation: University of Bristol
- Combination of direct and indirect evidence in mixed treatment comparisonsG Lu
MRC HSRC, Department of Social Medicine, University of Bristol, Canynge Hall, White Ladies Road, Bristol BS8 2PR, U K
Stat Med 23:3105-24. 2004..We discuss model critique and model selection, illustrating the role of Bayesian deviance analysis, and node-based model criticism. The assumptions underlying the MTC models and their parameterization are also discussed...
- Mapping from Disease-Specific to Generic Health-Related Quality-of-Life Scales: A Common Factor ModelGuobing Lu
School of Social and Community Medicine, University of Bristol, Bristol, UK Electronic address
Value Health 16:177-84. 2013..To develop a coherent method for estimating mappings between treatment effects on disease-specific measurement (DSM) instruments and generic health-related quality-of-life (QOL) measures, when both are subject to measurement errors...
- Meta-analysis of mixed treatment comparisons at multiple follow-up timesG Lu
MRC Health Services Research Collaboration, University of Bristol, Bristol, UK
Stat Med 26:3681-99. 2007..The extent of between-trials heterogeneity in treatment effects depends on treatment contrast. In discussion we note that models of this type have a very wide potential application...
- Modeling between-trial variance structure in mixed treatment comparisonsGuobing Lu
Department of Community Based Medicine, University of Bristol, Cotham House, Cotham Hill, Bristol BS6 6JL, UK
Biostatistics 10:792-805. 2009..The procedure is implemented in a MCMC framework and illustrated with example data sets from medical research practice...
- Mixed treatment comparison with multiple outcomes reported inconsistently across trials: evaluation of antivirals for treatment of influenza A and BN J Welton
Academic Unit of Primary Health Care, Department of Community Based Medicine, University of Bristol, Cotham House, Cotham Hill, Bristol BS6 6JL, U K
Stat Med 27:5620-39. 2008....
- Expected value of sample information calculations in medical decision modelingA E Ades
Medical Research Council Health Services Research Collaboration, Bristol, United Kingdom
Med Decis Making 24:207-27. 2004..Illustrative worked examples of EVSI calculations are given in an appendix...
- The interpretation of random-effects meta-analysis in decision modelsA E Ades
Medical Research Council, Health Services Research Collaboration, Canynge Hall, Bristol, UK
Med Decis Making 25:646-54. 2005....
- Correction: interpretation of random effects meta-analysis in decision modelsN J Welton
Med Decis Making 27:212-4. 2007
- Expression of cyclooxygenase-2, vascular endothelial growth factor and matrix metalloproteinase-2 in patients with primary laryngeal carcinoma: a tissue microarray studyP Dong
Department of Otolaryngology Head and Neck Surgery, Shanghai Jiao Tong University, Affiliated Shanghai First People s Hospital, China
J Laryngol Otol 121:1177-83. 2007..To determine the correlation between expression of cyclooxygenase-2, vascular endothelial growth factor and matrix metalloproteinase-2, in patients with laryngeal carcinoma...